Dr. Strother is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
980 W Walnut St
Indianapolis, IN 46202Phone+1 317-274-0136
Education & Training
- Indiana University School of MedicineFellowship, Clinical Pharmacology, 2005 - 2009
- Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2005 - 2009
- Indiana University School of MedicineResidency, Internal Medicine, 2003 - 2005
- Indiana University School of MedicineClass of 2003
Certifications & Licensure
- IN State Medical License 2006 - 2013
- New Zealand Medical CouncilSpecialist in Medical Oncology and Clinical Pharmacology
- Royal Australasian College of PhysiciansFellow
Publications & Presentations
PubMed
- 103 citationsA Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid TumorsElena G. Chiorean, Patricia LoRusso, Robert Matthew Strother, Jennifer R. Diamond, Anne Younger
Clinical Cancer Research. 2015-02-27 - 28 citationsTask Shifting and Skin Punch for the Histologic Diagnosis of Kaposi's Sarcoma in Sub-Saharan Africa: A Public Health Solution to a Public Health Problem.Miriam Laker-Oketta, Megan Wenger, Aggrey Semeere, Barbara Castelnuovo, Andrew Kambugu
Oncology. 2015-02-27 - 59 citationsAn Open-Label Phase Ib Dose-Escalation Study of TRC105 (Anti-Endoglin Antibody) with Bevacizumab in Patients with Advanced CancerMichael S. Gordon, Francisco Robert, Daniela Matei, David S. Mendelson, Jonathan W. Goldman
Clinical Cancer Research. 2014-12-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: